Greg Friberg will step into the role of executive vice president, chief research and development officer, succeeding Hank Fuchs.
Pharma ROI for research and development rose 4.1% in 2023 compared to a record low of 1.2% in 2022.
As part of this pivot in strategic communications, AbbVie is focusing its efforts on accelerating R&D and making cures a priority across various disease states.
The Inflation Reduction Act may disrupt a substantial amount of investment into finding new uses for already approved oncology drugs, researchers say.
The R&D investment made by the nearly dozen largest drug manufacturers totaled $104 billion last year.
Sanofi will be on the hook for additional payments if certain research, development and sales milestones are met by Insilico.
The consultancy’s annual report on R&D investment returns revealed a COVID-related bump in R&D investment returns.
The Number One agency on our Agency 100 list is collaborating with outside organizations to develop digital tools to help combat COVID-19.
Sander Flaum discusses the DISARM act and how we can fight back against antibiotic resistance.
As the country contends with the spread of the coronavirus, China’s next decade will see the evolution of health policy and regulation.
Get the most out of
Register for free and enjoy unlimited access to: